Anti-viral pill 89pc effective for high-risk Covid patients: Pfizer
Anti-viral pill 89pc effective for high-risk Covid patients: Pfizer
newKerala.com
0 shares
1 views
You might like
Related news coverage
COVID-19: Israel receives first Pfizer treatment pill shipment
Jerusalem Post
The pill, Paxlovid, are geared towards patients in mild to moderate conditions within the first three days of symptoms.
Advertisement
More coverage
U.S. Adds Merck Pill As 2nd Easy-To-Use Drug Against COVID-19
Newsy
Watch VideoU.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication..